| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |